The Indian Journal of Pediatrics

, Volume 84, Issue 7, pp 515–520 | Cite as

Correlation of Tissue Transglutaminase with Modified Marsh Grading in Celiac Disease: A Prospective Cohort Study

  • Rakesh Jora
  • Vikrant Raghuvanshi
  • Vikas Payal
  • Pramod Sharma
  • Shree Krishan Vishnoi
Original Article

Abstract

Objective

To find out correlation between serum anti-tissue transglutaminase immunoglobulin-A (tTGA) levels and Marsh grading on duodenal histopathology in Celiac disease (CD).

Methods

In a prospective cohort study, a total of 52 symptomatic patients between age group of 2–18 y were enroled. All enroled patients were subjected to upper GI endoscopy by an experienced endoscopist. Two biopsies each from the bulb (D1) and second part (D2) of the duodenum were taken and Marsh grading was performed by a single experienced pathologist. Serum tTGA levels were also performed to find out correlation between serum tTGA levels and Marsh grading.

Results

The mean age of the patients was 8.21 ± 3.45 y (Range: 2–16 y). Anemia was the most common non-gastrointestinal (GI) sign and was present in 73% of the cases. However the authors could not find out any significant association between Marsh grading and hemoglobin levels (r = 0.32, p > 0.05). Serum tTGA levels were found to be positively correlated with Marsh grading (Spearmen correlation coefficient ρ = 0.74, p 0.000). Significant differences were found in tTGA levels between different Marsh gradings (ANOVA test) (p 0.000). Receiver-operator curve (ROC) analysis cut-off value of serum tTGA for predicting villous atrophy was 178.8 (nine times of cut-off value) with sensitivity of 100% and specificity of 85.7%.

Conclusions

Serum tTGA levels can be used to predict villous atrophy and biopsy may be avoided in strongly suspected cases with more than 9 times of cut-offs.

Keywords

Celiac disease Marsh grading Upper GI endoscopy Tissue transglutaminase 

References

  1. 1.
    Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for celiac disease-related terms. Gut. 2013;62:43–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13–25.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–92.Google Scholar
  4. 4.
    Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001;120:636–51.CrossRefPubMedGoogle Scholar
  5. 5.
    Ciclitira PJ. Celiac disease: a technical review. Gastroenterology. 2001;120:1526–40.CrossRefPubMedGoogle Scholar
  6. 6.
    Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731–43.CrossRefPubMedGoogle Scholar
  7. 7.
    Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med. 2010;123:691–3.CrossRefPubMedGoogle Scholar
  8. 8.
    Lindfors K, Koskinen O, Kaukinen K. An update on the diagnostics of celiac disease. Int Rev Immunol. 2011;30:185–96.CrossRefPubMedGoogle Scholar
  9. 9.
    Mubarak A, Nikkels P, Houwen R, Ten Kate F. Reproducibility of the histological diagnosis of celiac disease. Scand J Gastroenterol. 2011;46:1065–73.CrossRefPubMedGoogle Scholar
  10. 10.
    Ravelli A, Villanacci V, Monfredini C, Martinazzi S, Grassi V, Manenti S. How patchy is patchy villous atrophy? Distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol. 2010;105:2103–10.CrossRefPubMedGoogle Scholar
  11. 11.
    Pais WP, Duerksen DR, Pettigrew NM, Bernstein CN. How many duodenal biopsy specimens are required to make a diagnosis of celiac disease? Gastrointest Endosc. 2008;67:1082–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Husby S, Koletzko S, Korponay-Szabó IR, et al; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–60.Google Scholar
  13. 13.
    Hill PG, Holmes GK. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther. 2008;27:572–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Dahlbom I, Korponay-Szabó IR, Kovács JB, Szalai Z, Mäki M, Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr. 2010;50:140–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Makharia GK, Verma AK, Amarchand R, et al. Prevalence of celiac disease in the northern part of India: a community based study. J Gastroenterol Hepatol. 2011;26:894–900.CrossRefPubMedGoogle Scholar
  16. 16.
    Aro P, Ronkainen J, Storskrubb T, et al. Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol. 2004;39:1280–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185–94.CrossRefPubMedGoogle Scholar
  19. 19.
    Mubarak A, Wolters VM, Gmelig-Meyling FH, Ten Kate FJ, Houwen RH. Tissue transglutaminase levels above 100 U/mL and celiac disease: a prospective study. World J Gastroenterol. 2012;18:4399–403.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Fernández-Bañares F, Alsina M, Modolell I, et al. Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of celiac disease. J Crohns Colitis. 2012;6:861–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Onyeador N, Jennings N, Paul SP, Ramani P, Sandhu BK. The relationship between tissue transglutaminase antibody titers and histological classification in celiac disease. Arch Dis Child. 2014;99:A34.CrossRefGoogle Scholar
  22. 22.
    Vivas S, Ruiz de Morales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol. 2009;15:4775–80.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Barker CC, Mitton C, Jevon G, Mock T. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics. 2005;115:1341–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Donaldson MR, Firth SD, Wimpee H, et al. Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol. 2007;5:567–73.CrossRefPubMedGoogle Scholar
  25. 25.
    Mubarak A, Wolters VM, Gerritsen SA, Gmelig-Meyling FH, Ten Kate FJ, Houwen RH. A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr. 2011;52:554–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Trovato CM, Montuori M, Anania C, et al. Are ESPGHAN “biopsy sparing” guidelines for celiac disease also suitable for asymptomatic patients? Am J Gastroenterol. 2015;110:1485–9.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2017

Authors and Affiliations

  • Rakesh Jora
    • 1
  • Vikrant Raghuvanshi
    • 1
  • Vikas Payal
    • 1
  • Pramod Sharma
    • 1
  • Shree Krishan Vishnoi
    • 1
  1. 1.Department of Pediatrics, Umaid Hospital for Women and Children, Dr. S.N. Medical CollegeJodhpurIndia

Personalised recommendations